Director/PDMR Shareholding

RNS Number : 8252U

Tintra PLC

30 March 2023

 

30 March 2023

TINTRA PLC

  ("Tintra", the "Group" or the "Company")

Director Dealing and Holding in the Company

The Company announces that Dr Joe Lyske, the Company's Chief Science Officer, has purchased a total of 47,207 ordinary shares of 1 pence each ("Ordinary Shares"). 

Following this purchase, Dr Lyske holds 108,002 Ordinary Shares (equivalent to 0.67% of the issued ordinary share capital).  In addition, he is a founder and person of significant control, but not a director, of Time Machine Capital 2 Limited, which holds 636,475 Ordinary Shares (equivalent to 3.94% of the issued ordinary share capital) and 636,475 warrants (full details as announced 24 November 2021).

Tintra PLC (Communications Head) Hannah Haffield [e-mail] Website www.tintra.com		020 3795 0421
Allenby Capital Limited (Nomad, Financial Adviser & Broker) John Depasquale / Nick Harriss / Vivek Bhardwaj		020 3328 5656
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Joe Lyske
2	Reason for the notification
a)	Position/status	PDMR (Chief Science Officer)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Tintra plc
b)	LEI	213800YKVH5ISMCNWJ42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1p GB00BHXM9D70
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 106.7p 106.7p 106.7p 15,000 13,636 18,571
d)	Aggregated information - Aggregated volume - Price	47,207 106.7p
e)	Date of the transaction	29 March 2023
f)	Place of the transaction	LSE

 

END

 

 

DSHBXGDXUSXDGXG